13D/13G Filings - Erytech Pharma S.A.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
12:41 pm
Sale		 2022-12-31 13G PHAXIAM Therapeutics S.A.
PHXM		 Armistice Capital, LLC 162,912
4.990%		 -110,813decrease
(-40.48%)		 Filing
History
2023-02-13
6:08 pm
Sale		 2022-12-31 13G PHAXIAM Therapeutics S.A.
PHXM		 BIOTECHNOLOGY VALUE FUND L P 51,724
1.600%		 -178,206decrease
(-77.50%)		 Filing
History
2022-12-23
5:08 pm
Sale		 2022-12-21 13G PHAXIAM Therapeutics S.A.
PHXM		 BIOTECHNOLOGY VALUE FUND L P 229,930
7.400%		 -281,988decrease
(-55.08%)		 Filing
History
2022-02-14
6:28 pm
Purchase		 2021-12-31 13G PHAXIAM Therapeutics S.A.
PHXM		 Armistice Capital, LLC 273,725
9.300%		 273,725increase
(New Position)		 Filing
History
2022-02-14
1:49 pm
Purchase		 2021-12-31 13G PHAXIAM Therapeutics S.A.
PHXM		 BIOTECHNOLOGY VALUE FUND L P 511,918
16.500%		 103,724increase
(+25.41%)		 Filing
History
2021-03-09
9:40 pm
Unchanged		 2021-03-08 13G PHAXIAM Therapeutics S.A.
PHXM		 BIOTECHNOLOGY VALUE FUND L P 408,194
19.300%		 0
(Unchanged)		 Filing
History
2021-01-29
4:36 pm
Sale		 2021-01-27 13D PHAXIAM Therapeutics S.A.
PHXM		 BIOTECHNOLOGY VALUE FUND L P 408,194
20.400%		 -38,000decrease
(-8.52%)		 Filing
History
2021-01-12
5:10 pm
Unchanged		 2021-01-08 13D PHAXIAM Therapeutics S.A.
PHXM		 BIOTECHNOLOGY VALUE FUND L P 446,194
22.300%		 0
(Unchanged)		 Filing
History
2020-10-13
5:18 pm
Sale		 2020-10-09 13D PHAXIAM Therapeutics S.A.
PHXM		 BIOTECHNOLOGY VALUE FUND L P 446,194
23.500%		 -8,572decrease
(-1.88%)		 Filing
History